35909335|t|Parthanatos participates in glutamate-mediated HT22 cell injury and hippocampal neuronal death in kainic acid-induced status epilepticus rats.
35909335|a|AIMS: Epileptic seizures or status epilepticus (SE) can cause hippocampal neuronal death, which has detrimental effects. Parthanatos, a new form of programmed cell death, is characterized by hyperactivation of poly (ADP-ribose) polymerase-1 (PARP-1), excessive synthesis of poly ADP-ribose polymer, mitochondrial depolarization, and nuclear translocation of apoptosis-inducing factor, observed in various neurodegenerative disorders but rarely reported in epilepsy. We aimed to investigate whether parthanatos participates in the mechanism of seizure-induced hippocampal neuronal death. METHODS: Glutamate-mediated excitotoxicity cell model was used to study the mechanism of seizure-induced cell injury. Injection of kainic acid into the amygdala was used to establish the epileptic rat model. Corresponding biochemical tests were carried out on hippocampal tissues and HT22 cells following indicated treatments. RESULTS: In vitro, glutamate time-dependently induced HT22 cell death, accompanied by parthanatos-related biochemical events. Pretreatment with PJ34 (PARP-1 inhibitor) or small interfering RNA-mediated PARP-1 knockdown effectively protected HT22 cells against glutamate-induced toxic effects and attenuated parthanatos-related biochemical events. Application of the antioxidant N-acetylcysteine (NAC) rescued HT22 cell death and reversed parthanatos-related biochemical events. In vivo, PJ34 and NAC afforded protection against SE-induced hippocampal neuronal damage and inhibited parthanatos-related biochemical events. CONCLUSION: Parthanatos participates in glutamate-induced HT22 cell injury and hippocampal neuronal damage in rats following epileptic seizures. ROS might be the initiating factor during parthanatos.
35909335	0	11	Parthanatos	Disease	
35909335	28	37	glutamate	Chemical	MESH:D018698
35909335	47	51	HT22	CellLine	CVCL:0321
35909335	52	63	cell injury	Disease	MESH:D002280
35909335	68	79	hippocampal	Disease	MESH:D000092223
35909335	80	94	neuronal death	Disease	MESH:D009410
35909335	98	109	kainic acid	Chemical	MESH:D007608
35909335	118	136	status epilepticus	Disease	MESH:D013226
35909335	137	141	rats	Species	10116
35909335	149	167	Epileptic seizures	Disease	MESH:D004827
35909335	171	189	status epilepticus	Disease	MESH:D013226
35909335	191	193	SE	Disease	MESH:D013226
35909335	205	216	hippocampal	Disease	MESH:D000092223
35909335	217	231	neuronal death	Disease	MESH:D009410
35909335	264	275	Parthanatos	Disease	
35909335	353	383	poly (ADP-ribose) polymerase-1	Gene	11545
35909335	385	391	PARP-1	Gene	25591
35909335	417	440	poly ADP-ribose polymer	Chemical	-
35909335	442	470	mitochondrial depolarization	Disease	MESH:D028361
35909335	548	575	neurodegenerative disorders	Disease	MESH:D019636
35909335	599	607	epilepsy	Disease	MESH:D004827
35909335	641	652	parthanatos	Disease	
35909335	686	693	seizure	Disease	MESH:D012640
35909335	702	713	hippocampal	Disease	MESH:D000092223
35909335	714	728	neuronal death	Disease	MESH:D009410
35909335	739	748	Glutamate	Chemical	MESH:D018698
35909335	758	772	excitotoxicity	Disease	
35909335	819	826	seizure	Disease	MESH:D012640
35909335	835	846	cell injury	Disease	MESH:D002280
35909335	861	872	kainic acid	Chemical	MESH:D007608
35909335	917	926	epileptic	Disease	MESH:D004827
35909335	927	930	rat	Species	10116
35909335	990	1001	hippocampal	Disease	MESH:D000092223
35909335	1014	1018	HT22	CellLine	CVCL:0321
35909335	1076	1085	glutamate	Chemical	MESH:D018698
35909335	1111	1115	HT22	CellLine	CVCL:0321
35909335	1143	1154	parthanatos	Disease	
35909335	1201	1205	PJ34	Chemical	MESH:C434926
35909335	1207	1213	PARP-1	Gene	11545
35909335	1259	1265	PARP-1	Gene	11545
35909335	1298	1302	HT22	CellLine	CVCL:0321
35909335	1317	1326	glutamate	Chemical	MESH:D018698
35909335	1364	1375	parthanatos	Disease	
35909335	1435	1451	N-acetylcysteine	Chemical	MESH:D000111
35909335	1453	1456	NAC	Chemical	MESH:D000111
35909335	1466	1470	HT22	CellLine	CVCL:0321
35909335	1495	1506	parthanatos	Disease	
35909335	1544	1548	PJ34	Chemical	MESH:C434926
35909335	1553	1556	NAC	Chemical	MESH:D000111
35909335	1585	1587	SE	Disease	MESH:D013226
35909335	1596	1607	hippocampal	Disease	MESH:D000092223
35909335	1608	1623	neuronal damage	Disease	MESH:D009410
35909335	1638	1649	parthanatos	Disease	
35909335	1718	1727	glutamate	Chemical	MESH:D018698
35909335	1736	1740	HT22	CellLine	CVCL:0321
35909335	1741	1752	cell injury	Disease	MESH:D002280
35909335	1757	1768	hippocampal	Disease	MESH:D000092223
35909335	1769	1784	neuronal damage	Disease	MESH:D009410
35909335	1788	1792	rats	Species	10116
35909335	1803	1821	epileptic seizures	Disease	MESH:D004827
35909335	1823	1826	ROS	Chemical	-
35909335	1865	1876	parthanatos	Disease	
35909335	Positive_Correlation	MESH:D018698	MESH:D009410
35909335	Negative_Correlation	MESH:D000111	MESH:D009410
35909335	Negative_Correlation	MESH:D000111	MESH:D013226
35909335	Negative_Correlation	MESH:C434926	MESH:D018698
35909335	Negative_Correlation	MESH:C434926	11545
35909335	Positive_Correlation	MESH:D007608	MESH:D013226
35909335	Association	MESH:D018698	11545
35909335	Negative_Correlation	MESH:C434926	MESH:D013226
35909335	Negative_Correlation	MESH:C434926	MESH:D000092223
35909335	Positive_Correlation	MESH:D007608	MESH:D004827
35909335	Positive_Correlation	MESH:D018698	MESH:D002280
35909335	Negative_Correlation	MESH:C434926	MESH:D009410

